Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 56,502 | 44,814 | 75,453 | 54,475 | 52,436 |
| Cost of Goods | 12,475 | 10,424 | 23,127 | 12,173 | 12,301 |
| Gross Profit | 44,027 | 34,390 | 52,326 | 42,302 | 40,135 |
| Operating Expenses | 36,917 | 38,642 | 35,347 | 32,902 | 33,800 |
| Operating Income | 7,585 | -3,828 | 17,106 | 9,573 | 6,636 |
| Interest Expense | 180 | 731 | 1,119 | 1,489 | 1,837 |
| Other Income | 840 | 1,132 | 1,120 | 1,159 | 1,366 |
| Pre-tax Income | 8,245 | -3,427 | 17,107 | 9,243 | 6,165 |
| Income Tax | 56 | 326 | 3,669 | 399 | 310 |
| Net Income Continuous | 8,189 | -3,753 | 13,438 | 8,844 | 5,855 |
| Net Income | $8,189 | $-3,753 | $13,438 | $8,844 | $5,855 |
| EPS Basic Total Ops | 0.16 | -0.07 | 0.26 | 0.18 | 0.12 |
| EPS Basic Continuous Ops | 0.16 | -0.07 | 0.27 | 0.18 | 0.12 |
| EPS Diluted Total Ops | 0.16 | -0.07 | 0.26 | 0.17 | 0.12 |
| EPS Diluted Continuous Ops | 0.16 | -0.07 | 0.26 | 0.17 | 0.12 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.07 | 0.26 | 0.17 | 0.12 |
| EBITDA(a) | $10,101 | $-1,244 | $19,763 | $12,295 | $9,399 |